Preclinical Alzheimer Disease—Early Diagnosis or Overdiagnosis?

This Viewpoint argues that the shift from treating patients with symptomatic Alzheimer disease to treating those with preclinical disease carries the risk of overdiagnosis.

Read the full article here

Related Articles